Yale University Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Yale University

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $1.15 Million - $1.62 Million	-11,668 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $747,568 - $1.07 Million	11,668 New	11,668 $798,000
Q4 2017 Feb 09, 2018	SELL	$20.44 - $35.56 $5.11 Million - $8.89 Million	-250,000 Closed	0 $0
Q3 2017 Nov 30, 2018	BUY	$23.54 - $38.21 $5.89 Million - $9.55 Million	250,000 New	250,000 $9.35 Million
Q3 2017 Nov 17, 2017	SELL	$23.54 - $38.21 $5.89 Million - $9.55 Million	-250,000 Closed	0 $0
Q2 2017 Nov 30, 2018	BUY	N/A	250,000	250,000 $6.25 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.39B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Yale University, based on Form 13F filings with the SEC.

Stay updated on Yale University with notifications on news.